Are you sure?

Egis Pharmaceutical Rt ownership changes

According to FTIF Templeton Eastern Fund, the fund purchased a 5.06 per cent stake of Egis Rt from Templeton Developing Markets Trust, as well as a 0.07% per cent Egis stake from Templeton Emerging Markets Trust. After the company?s share restructuring, FTIF Templeton Eastern Fund holds a 5.13 per cent stake of Egis Pharmaceutical Rt from January 5.